Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

By T. Ahles, Andrew J. Saykin, C. Furstenberg, B. Cole, L. Mott, K. Skalla, M. Whedon, Sarah E Bivens, T. Mitchell, E. Greenberg and 1 more. Journal of Clinical Oncology, 2002

749 citations recorded by the source corpus.

Subfields: Genetics, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/d4c2a1a1c815e758f1b2c907bcfc53d6f0bdc600

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. Shelli R. Kesler
2. A. Jemal
3. R. Siegel
4. T. Ahles

In Pulmonary and Respiratory Medicine

1. Shelli R. Kesler
2. A. Jemal
3. Elizabeth E. Ward
4. R. Siegel
5. T. Ahles

Citations in the corpus

• Cytokines and their relationship to the symptoms and outcome of cancer (2008, background): “Fatigue and cognitive decline have a negative impact on quality of life and such symptoms can persist for at least 10 years in some breast cancer survivor”
• PREVALENCE, MECHANISMS, AND MANAGEMENT OF CANCER-RELATED COGNITIVE IMPAIRMENT (2014, background): “…during the mid 1990s to early 2000s ISSN 0954–0261 print/ISSN 1369–1627 online © 2014 Institute of Psychiatry DOI: 10.3109/09540261.2013.864260 (Ahles et al., 2002; Brezden et al., 2000; Paraska & Bender, 2003; van Dam et al., 1998; Wieneke, 1995); these studies initially established CRCI…”
• Cancer treatment and survivorship statistics, 2012 (2012, background): “Although only a subgroup of survivors suffer long-term cognitive dysfunction, these deficits can be debilitating.(80,81) Long-term survivors of breast, lung, and ovarian cancers and lymphoma may have cognitive(82-87) and neurological(88) complications caused by systemic chemotherapy.”